German pharma antitrust in 40 questions - a practitioner’s guide
Blog Post
28 July 2022
Browse this blog post
Related news and insights
Blog Post: 03 April 2024
European Commission opens unprecedented abuse of dominance probe in animal medicines sector
Publications: 02 April 2024
Blog Post: 28 March 2024
Publications: 07 March 2024
Our Hamburg-based German antitrust team has contributed a chapter on Germany to Lexology Get The Deal Through’s global report on Pharmaceutical Antitrust.
In their contribution, they provide guidance on the regulatory framework, merger control aspects and potential enforcement risks with regard to anticompetitive agreements as well as anticompetitive unilateral conduct for those active in the German pharmaceutical sector.